Drug Pipeline

Organoid Drug Sensitivity Testing-Guided Therapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07351513 A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable… Unresectable Hepatocellular Carcinoma Not Yet Recruiting
NCT07351591 A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable… Advanced Biliary Tract Cancer(BTC) Not Yet Recruiting
NCT07363356 Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After… Hepatocellular Carcinoma Resectable Not Yet Recruiting
Sponsors Running Organoid Drug Sensitivity Testing-Guided Therapy Trials
Eastern Hepatobiliary Surgery Hospital (3)
Disease Areas
Liver Cancer (2) Cholangiocarcinoma (1)
Get alerts when Organoid Drug Sensitivity Testing-Guided Therapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free